Correlation of renal organic anion and cation transport with blood pressure in SHR.
In 1974, we found that sera from SHR suppressed renal PAH transport (PSEBM 145:97, 1974). Since a "natriuretic factor" depresses PAH as well as Na transport, we proposed that "natriuretic factor" was elevated in SHR. Our current investigation amplifies the previous study. On a given day, one spontaneously hypertensive rat (SHR) and one rat from a normotensive strain [Wistar Kyoto (WKY) or Sprague-Dawley (SD]) were examined together. SHR sera compared to WKY/SD sera significantly depress PAH (organic anion) and TEA (organic cation) uptake by rat renal slices. The ability of SHR sera to depress uptake correlated significantly with the BP: the sera with the greatest depressive influence on renal PAH and TEA uptake came from the SHR with the highest BP (PAH r = 0.89, p less than 0.0001; TEA = r = 0.76, p less than 0.01). Subsequent separation of serum on Sephadex 25 localized the factor to the same fraction as "natriuretic hormone". A similar correlation was found between the ability of the fraction to depress the 2 transports and the height of the BP. The serum factor did not inhibit ATPase activity. In contrast to the serum effects, renal slices removed from SHR showed increased rather than decreased PAH and TEA transport which significantly correlated with the BP. The slices with the highest uptakes came from the SHR with the highest BP. The high uptake of organic ions by the SHR renal slices could be an adaptive response to the serum factor or vice versa. We postulate that a serum factor which depresses PAH and TEA transport and is not "ouabain-like" may play a role in the BP elevation of SHR.
Gharib
N
N
Georgetown University Medical Center, Department of Medicine, Washington, D.C. 200007.
Gao
C Y
CY
Areas
J L
JL
el Zein
M
M
Preuss
H G
HG
D000136:Acid-Base Equilibrium / Q000502:physiology*; D000818:Animals; D001693:Biological Transport, Active / Q000502:physiology; D001794:Blood Pressure / Q000502:physiology*; D006973:Hypertension / Q000097:blood*; D066298:In Vitro Techniques; D007668:Kidney / Q000502:physiology*; D045283:Natriuretic Agents / Q000097:blood / Q000502:physiology*; D051381:Rats; D011918:Rats, Inbred SHR / Q000502:physiology*; D011919:Rats, Inbred Strains; D011921:Rats, Inbred WKY; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors; D019789:Tetraethylammonium; D013757:Tetraethylammonium Compounds / Q000378:metabolism; D010130:p-Aminohippuric Acid / Q000378:metabolism
D045283:Natriuretic Agents; D013757:Tetraethylammonium Compounds; D019789:Tetraethylammonium; D000254:Sodium-Potassium-Exchanging ATPase; D010130:p-Aminohippuric Acid